Glenmark Pharma. (GLENMARK)
FAST GROWERFairStock Score: 42/100 — MIXED
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2,337.2 |
| Market Cap | ₹60,297.85 Cr |
| P/E Ratio | 22.28 |
| ROCE | 19.4% |
| ROE | 12.04% |
| Dividend Yield | 0.12% |
| Profit Growth | 55.23% |
| Debt/Equity | 0.13 |
| Sales Growth | 25.44% |
| Free Cash Flow | ₹-77,000 Cr |
| Promoter Holding | 46.65% |
| 52-Week Range | ₹1,605 — ₹2,471.05 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹313.59 |
Glenmark Pharma. trades with a P/E ratio of 22.28, ROCE of 19.4%, ROE of 12.04%, profit growth of 55.23%, debt-to-equity of 0.13. The FairStock Score of 42/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer